If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Emgality ® (galcanezumab-gnlm) injection
100 mg/mL, 120 mg/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
EMGALITY® (galcanezumab-gnlm): Sales Rep
To request a sales representative visit for Emgality, please complete and submit the electronic request form.
Detailed Information
To request a sales representative visit, please complete and submit the Sales Representative Request Form.
Date of Last Review: April 02, 2021